Article: Methylin Oral Solution is Child Preferred.

Alliant Pharmaceuticals announces preliminary results of study on convenience and compliance of Methylin Oral Solution for treating ADHD

ALPHARETTA, Ga., Oct. 30 /PRNewswire-FirstCall/ -- Alliant Pharmaceuticals, Inc. a pediatric specialty pharmaceutical company, today announced preliminary results of the company's sponsored survey on Methylin Oral Solution. The survey, Methylin Oral Solution in ADHD Patients to Investigate Satisfaction, Convenience and Compliance, or MOSAIC, will evaluate Methylin Oral Solution in up to 5,000 patients at more than 500 sites.

MOSAIC studies began in the second quarter of this year with enrollment and activity continuing ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!